All In Biotech

Drug Trial Radar · NCT02462083

Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

A Phase 3, Multicenter, Open Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

555

Actual

Start

Aug 11, 2015

Primary completion

Jan 31, 2017

Study completion Apr 24, 2017

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
Collaborators
Dow Pharmaceutical Sciences
First posted
Jun 3, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the long-term safety of IDP-118 lotion.

Conditions

  • Plaque Psoriasis

Interventions

  • IDP-118 LotionDrug

    IDP-118 lotion will be applied as per the instructions provided by the investigational center staff.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Experienced Grade 3 Local Skin ReactionsTime frame: Baseline up to Week 52

Locations

46 sites in 1 country. Site status is shown where the registry gives one.

  • Valeant Site 6

    Mobile, Alabama

  • Valeant Site 24

    Beverly Hills, California

  • Valeant Site 32

    Encinitas, California

  • Valeant Site 27

    Encino, California

  • Valeant Site 33

    Los Angeles, California

  • Valeant Site 43

    Los Angeles, California

  • Valeant Site 45

    Sacramento, California

  • Valeant Site 25

    San Diego, California

  • Valeant Site 4

    San Diego, California

  • Valeant Site 44

    Santa Monica, California

  • Valeant Site 36

    Santa Rosa, California

  • Valeant Site 10

    Englewood, Colorado

  • Valeant Site 3

    Boynton Beach, Florida

  • Valeant Site 28

    Coral Gables, Florida

  • Valeant Site 1

    Miami, Florida

  • Valeant Site 37

    North Miami Beach, Florida

  • Valeant Site 13

    Sanford, Florida

  • Valeant Site 41

    Snellville, Georgia

  • Valeant Site 17

    South Bend, Indiana

  • Valeant Site 12

    Olathe, Kansas

  • Valeant Site 19

    Louisville, Kentucky

  • Valeant Site 14

    Louisville, Kentucky

  • Valeant Site 35

    Clinton Township, Michigan

  • Valeant Site 34

    Detroit, Michigan

  • Valeant Site 16

    Warren, Michigan

  • Valeant Site 18

    Fridley, Minnesota

  • Valeant Site 31

    Omaha, Nebraska

  • Valeant Site 2

    East Windsor, New Jersey

  • Valeant Site 29

    New York, New York

  • Valeant Site 39

    Rochester, New York

  • Valeant Site 5

    Portland, Oregon

  • Valeant Site 11

    Philadelphia, Pennsylvania

  • Valeant Site 30

    Charleston, South Carolina

  • Valeant Site 15

    Nashville, Tennessee

  • Valeant Site 9

    Dallas, Texas

  • Valeant Site 40

    Houston, Texas

  • Valeant Site 8

    Houston, Texas

  • Valeant Site 46

    Katy, Texas

  • Valeant Site 20

    Pflugerville, Texas

  • Valeant Site 21

    San Antonio, Texas

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.